NQO1 regulates cell cycle progression at the G2/M phase

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Cycle Regulation

Background:

• Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) is linked to cancer cell proliferation.
• The precise mechanisms of NQO1's role in cell cycle progression remain largely unknown.

Purpose of the Study:

• To elucidate the novel function of NQO1 in regulating cell cycle progression.
• To investigate the NQO1/c-Fos/CKS1 signaling pathway in cancer cells.

Main Methods:

• Cell cycle synchronization and flow cytometry were used to analyze cell cycle progression.
• siRNA, overexpression systems, co-immunoprecipitation, and immunohistochemistry were employed to study the NQO1/c-Fos/CKS1 pathway.
• Publicly available datasets were analyzed to correlate NQO1 expression with patient outcomes.

Main Results:

• NQO1 directly interacts with c-Fos, inhibiting its proteasomal degradation and upregulating CKS1 expression.
• NQO1 deficiency suppressed c-Fos-mediated CKS1 expression and cell cycle progression at the G2/M phase.
• High NQO1 expression correlated with increased CKS1 levels and poorer prognosis in cancer patients.

Conclusions:

• NQO1 plays a novel regulatory role in cancer cell cycle progression at the G2/M phase.
• The NQO1/c-Fos/CKS1 signaling axis is a key mechanism controlling cell cycle progression in cancer.
• NQO1 may serve as a potential therapeutic target for cancer treatment.